Evidence method
Level · gp.fundamentals.debt_to_revenue
11.89% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Dec 31, 2020
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-21-000008General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
8.12% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
22.01% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
16.69% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
14.97% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
35.76% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
18.95% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.18% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.58% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 46.66%
- Current
- 11.89%
- Delta
- -34.77%
- Previous
- 8.67%
- Current
- 8.12%
- Delta
- -0.54%
- Previous
- 21.64%
- Current
- 22.01%
- Delta
- 0.37%
- Previous
- 20.15%
- Current
- 16.69%
- Delta
- -3.46%
- Previous
- 53.81%
- Current
- 14.97%
- Delta
- -38.85%
- Previous
- 35.51%
- Current
- 35.76%
- Delta
- 0.25%
- Previous
- 18.10%
- Current
- 18.95%
- Delta
- 0.85%
- Previous
- 2.28%
- Current
- 2.18%
- Delta
- -0.10%
- Previous
- 1.82%
- Current
- 1.58%
- Delta
- -0.24%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · WST CAPEX_INTENSITY_DECREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST GROWTH_DECREASED →Transitioned To · WST INVENTORY_PRESSURE_DECREASED →Transitioned To · WST MARGIN_INCREASED →Transitioned To · WST PROFITABILITY_INCREASED →Transitioned To · WST R_AND_D_INTENSITY_DECREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.